Murraya koenigii (Murraya koenigii): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Murraya koenigii lower blood sugar levels?

Murraya koenigii (curry leaf) exerts anti-diabetic effects through multiple mechanisms. Its carbazole alkaloids, particularly mahanine, enhance insulin secretion from pancreatic beta-cells and improve insulin sensitivity in peripheral tissues. The herb also inhibits carbohydrate-digesting enzymes like alpha-amylase, slowing glucose absorption. Additionally, its antioxidant compounds protect pancreatic cells from oxidative damage. These combined actions help regulate blood glucose levels, supporting its traditional use in diabetes management (Evidence level C).

Does curry leaf interact with diabetes medications?

Yes, Murraya koenigii may interact with hypoglycemic medications. Because curry leaf naturally lowers blood glucose, combining it with diabetes drugs like metformin, sulfonylureas, or insulin may potentiate effects and increase hypoglycemia risk. Patients taking anticoagulants should also exercise caution, as curry leaf compounds may affect platelet aggregation. Monitor blood glucose closely if using curry leaf therapeutically alongside diabetes medications, and consult a healthcare provider for appropriate dose adjustments (Evidence level C).

What is the recommended dosage for curry leaf powder?

For therapeutic purposes, 1-2 grams of dried Murraya koenigii leaf powder taken twice daily is commonly recommended. Fresh leaves can be consumed liberally as a culinary herb in cooking. Consistency is important for managing chronic conditions like diabetes. Start with lower doses and gradually increase while monitoring blood glucose response. Standardized extracts may have different dosing requirements, so follow manufacturer guidelines or consult a qualified herbalist (Evidence level C, Traditional use).

Is Murraya koenigii safe during pregnancy and breastfeeding?

Curry leaf is considered safe during pregnancy and breastfeeding when consumed in normal culinary amounts. Murraya koenigii has a long history of use in South Asian cuisine without documented adverse effects on maternal or fetal health. However, therapeutic doses or concentrated supplements have not been rigorously studied in pregnant populations. Pregnant women should stick to food-level consumption and consult their healthcare provider before using curry leaf in medicinal quantities (Evidence level: Traditional use).

What are the main health benefits of curry leaves?

Murraya koenigii offers several evidence-supported health benefits. Its primary uses include blood sugar regulation in type 2 diabetes, cholesterol reduction, and antioxidant protection against cellular damage. Traditional applications include promoting hair growth, treating anemia due to its iron content, supporting digestion, and managing diarrhea. The herb's carbazole alkaloids, flavonoids, and phenolic acids contribute to these therapeutic properties. While promising, most evidence comes from preclinical studies with limited human clinical trials (Evidence level C).

Can curry leaves cause side effects?

Murraya koenigii is generally well-tolerated when consumed in culinary or recommended therapeutic doses. The primary safety concern is hypoglycemia, particularly when taking high doses or combining with diabetes medications. Symptoms may include dizziness, sweating, confusion, and fatigue. Those with low blood sugar should avoid therapeutic doses. No serious toxicity has been reported at standard doses, but individuals with known allergies to Rutaceae family plants should exercise caution (Evidence level C).

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Murraya koenigii, commonly known as curry leaf or sweet neem, is a tropical plant native to India and Southeast Asia used in Ayurveda for its diverse medicinal properties [PMID:39253925, PMID:31991665].

Background

Murraya koenigii (family: Rutaceae) is a medicinally important herb of Indian origin [PMID:39253925, PMID:31991665]. Almost every part of the plant, including fresh leaves, fruits, bark, and roots, is utilized for therapeutic purposes [PMID:39253925].

Traditional uses

In Ayurveda, fresh leaves are used to treat piles, inflammation, itching, fresh cuts, dysentery, and edema [PMID:39253925]. A combination of curry leaf and buttermilk is used for amoebiasis, diabetes, and hepatitis [PMID:39253925]. The bark is traditionally used for snakebites, and the roots are used for body aches [PMID:39253925]. It is also used for skin eruptions, emesis, and bruises [PMID:38878841].

Active compounds

The plant is a rich source of carbazole alkaloids, including mahanine (the principal bioactive component), girinimbine, koenimbine, and mahanimbine [PMID:29175114, PMID:37678421]. Other identified compounds include terpenoids, monoterpenes (such as α-pinene and β-caryophyllene), sesquiterpenes, flavonoids, phenols, and minor furocoumarins (e.g., xanthotoxin, phellopterin) [PMID:33588087, PMID:37516925, PMID:10844176, PMID:31749498].

Mechanism of action

Anticancer effects are mediated by targeting pathways associated with apoptosis, growth (JAK-STAT, mTOR), and the cell cycle, as well as regulating molecular pathways including Bcl-2, Bax, NF-κB, and TNFα [PMID:33588087, PMID:34754314]. Nootropic effects may be attributed to pro-cholinergic activity and cholesterol-lowering properties [PMID:18844259].

Clinical evidence

Evidence DCognitive Impairment/Amnesia

Leaf extracts significantly improved memory scores and reduced amnesia induced by scopolamine and diazepam in mice [PMID:18844259]; ethanolic and aqueous extracts improved cognitive impairment in Alloxan-induced diabetic rats [PMID:36937470].

Evidence DObesity and Diabetes

Alkaloid enriched fractions ameliorated high-fat diet-induced obesity and metabolic complexities in mice [PMID:38878841]; reported anti-obesity and anti-diabetic activity in in vitro and in vivo studies [PMID:39253925].

Evidence DCancer

Mahanine and leaf extracts demonstrated cytotoxic effects and protective potential against DMBA-induced breast carcinogenesis in rats [PMID:29175114, PMID:37678421, PMID:34566312].

Evidence DHyperlipidemia

Ethanolic leaf extract improved the lipid profile of rats fed with cholesterol-enriched diets [PMID:38243555].

Evidence DCardiotoxicity

Leaf extract showed cardioprotective potential against doxorubicin-induced cardiotoxicity in rats [PMID:32308710].

Evidence summary

The current evidence is primarily based on in vitro studies, animal models (rats/mice), and literature reviews. There is a lack of human clinical trial data to establish clinical efficacy and safety.

PubMed sources

1.PMID: 39253925 (2024) — Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review. · Current pharmaceutical design
2.PMID: 35215300 (2022) — Multi-Target Approach of Murraya koenigii Leaves in Treating Neurodegenerative Diseases. · Pharmaceuticals (Basel, Switzerland)
3.PMID: 31991665 (2020) — Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds. · Antioxidants (Basel, Switzerland)
4.PMID: 29175114 (2018) — Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine. · Pharmacological research
5.PMID: 34754314 (2021) — Nutritive Importance and Therapeutics Uses of Three Different Varieties (Murraya koenigii, Micromelum minutum, and Clausena indica) of Curry Leaves: An Updated Review.

Murraya koenigii

Sources & Citations

Calculate a safe dose of Murraya koenigii